Industries

Medtech

Serving as strategic business partners to 350+ medical device and medtech companies around the world

Practices

  • Unparalleled access to the largest and most influential network of leading venture capitalists, financial institutions and others strategic partners that service the medical device industry
    Regularly represent target companies opposite larger medical device/technology companies on strategic investments, corporate partnering and commercialization deals and M&A transactions
    20%
    Advised on 20% of medical device and medtech IPOs in the past 5 years for companies like Amedica, Intersect ENT, T2 Biosystems and TriVascular Technologies
    275+
    medical device and life sciences M&A transactions since 2010, including deals for Auxogyn, CardioMEMS, Medidata, Protein Simple and Volcano Corporation
    230+
    medical device and life sciences venture financings raising an aggregate of $7+ billion since 2015 for companies like EndoGastric Solutions, Avedro, CardioDx, Proteus Digital Health and SynCardia
    Read more
Unparalleled access to the largest and most influential network of leading venture capitalists, financial institutions and others strategic partners that service the medical device industry
Regularly represent target companies opposite larger medical device/technology companies on strategic investments, corporate partnering and commercialization deals and M&A transactions
20%
Advised on 20% of medical device and medtech IPOs in the past 5 years for companies like Amedica, Intersect ENT, T2 Biosystems and TriVascular Technologies
275+
medical device and life sciences M&A transactions since 2010, including deals for Auxogyn, CardioMEMS, Medidata, Protein Simple and Volcano Corporation
230+
medical device and life sciences venture financings raising an aggregate of $7+ billion since 2015 for companies like EndoGastric Solutions, Avedro, CardioDx, Proteus Digital Health and SynCardia
Read more

350+

medtech companies represented around the world

Life Sciences Resources

From startup to scale, our industry resources equip life sciences leaders with curated insights on regulatory developments, financing trends, IP strategies and key legal considerations shaping the life sciences landscape

Learn more

Group contacts

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.